SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sangamo Therapeutics, Inc. SGMO
SGMO 0.511-3.5%10:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (4)4/6/2000 11:37:00 PM
From: sim1  Read Replies (1) of 368
 
>>(these are two big names to follow).......<<

[Greisman HA, Pabo CO]

For the one or two others who also might not have made the connection -

From Sangamo's Web Site...

Carl Pabo, Ph.D. (Chairman [Sangamo Scientific Advisory Board]) Dr. Pabo joined the Scientific Advisory Board as Chairman in October 1999. Dr. Pabo is Professor of Biophysics and Structural Biology at the Massachusetts Institute of Technology and Investigator, Howard Hughes Medical Institute. Through his efforts to understand how ZFPs bind to and recognize specific DNA sequences, Dr. Pabo has made many of the fundamental observations that have driven the ZFP field over the last ten years. Dr. Pabo, together with Nikola Pavletich, solved and published the first crystal structure of a ZFP bound to its cognate DNA sequence (Science, 1991); perhaps the seminal publication in the field of ZFP rational design.

Thanks Rick,

Stuart

(still looking for Greisman)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext